Skip to main content

MINI REVIEW article

Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1450441
This article is part of the Research Topic Metabolic reprogramming in cancer View all 11 articles

Cancer metabolic reprogramming and Precision Medicine-Current perspective

Provisionally accepted
Tingting Gao Tingting Gao 1Liuxin Yang Liuxin Yang 2Yali Zhang Yali Zhang 1Ousman Bajinka Ousman Bajinka 3Xingxing Yuan Xingxing Yuan 1*
  • 1 Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China
  • 2 School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China
  • 3 School of Medicine and Allied Health Sciences, University of the Gambia, Serekunda, Gambia

The final, formatted version of the article will be published soon.

    Despite the advanced technologies and global attention on cancer treatment strategies, cancer continues to claim lives and adversely affects socio-economic development. Although combination therapies were anticipated to eradicate this disease, the resilient and restorative nature of cancers allows them to proliferate at the expense of host immune cells energetically. This proliferation is driven by metabolic profiles specific to the cancer type and the patient. An emerging field is exploring the metabolic reprogramming (MR) of cancers to predict effective treatments. This mini-review discusses the recent advancements in cancer MR that have contributed to predictive, preventive, and precision medicine. Current perspectives on the mechanisms of various cancer types and prospects for MR and personalized cancer medicine are essential for optimizing metabolic outputs necessary for personalized treatments.

    Keywords: metabolic reprogramming, precision medicine, treatment strategies, immune cell, Mechanism

    Received: 17 Jun 2024; Accepted: 04 Oct 2024.

    Copyright: © 2024 Gao, Yang, Zhang, Bajinka and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xingxing Yuan, Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.